15 Best 52-Week Low Dividend Stocks to Invest In
Dividend stocks have traditionally attracted long-term investors, but they are often overshadowed by flashy growth stocks in terms of popularity.
Insider Monkey Blog
RBC Capital Remains Bullish on Viridian Therapeutics (VRDN) Following Q3 2025 Results
On November 6, 2025, RBC Capital raised its price target on Viridian Therapeutics, Inc. (NASDAQ:VRDN) from $41 to $45, while maintaining an “Outperform” rating.
UroGen Pharma (URGN) Closes Q3 2025 With $127.4 Million in Cash Amid Rising R&D Costs
On November 6, 2025, UroGen Pharma Ltd. (NASDAQ:URGN) reported its Q3 2025 results, highlighting strong growth in demand alongside its steady commercial expansion.
Raymond James Remains Bullish on Liquidia (LQDA), Cites YUTREPIA’s 75% Growth in U.S. Prostacyclin Revenue
On November 4, 2025, Raymond James raised its price target on Liquidia Corporation (NASDAQ:LQDA) from $41 to $47, while reiterating a “Strong Buy” rating.
Edgewise Therapeutics (EWTX) Reports Heightened R&D Activity in Q3 2025
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) reported its Q3 2025 results on November 6, 2025.
BMO Capital Remains Bullish on Structure Therapeutics (GPCR), Cites Upcoming Trial Readouts
On November 10, 2025, BMO Capital reiterated its “Outperform” rating on Structure Therapeutics Inc. (NASDAQ:GPCR), setting a $100 price target.
H.C. Wainwright Maintains Its Bullish Stance on Vera Therapeutics (VERA), Sees Strong Future Revenue Growth
On November 10, 2025, The Fly reported that H.C. Wainwright increased its price target on Vera Therapeutics, Inc.
Jones Trading Remains Bullish on Janux Therapeutics (JANX) Amid Promising Developments in Prostate Cancer Program
On November 11, 2025, Jones Trading’s Soumit Roy reiterated his “Buy” rating on Janux Therapeutics, Inc.
Jefferies Maintains “Buy” Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning
On November 13, 2025, Jefferies analyst Roger Song noted that Wave Life Sciences Ltd.
William Blair Maintains Bullish Stance on Biohaven (BHVN), Sees Robust Operational Growth
On November 11, 2025, William Blair kept its “Market Perform” rating.
JPMorgan Reduces PT on Syndax Pharmaceuticals (SNDX) to $33, Maintains “Overweight” Rating
On November 12, 2025, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) saw JPMorgan reduce its price target from $40 to $33, while reiterating its “Overweight” rating.
Sealed Air (SEE) Climbs 18% on Takeover Bid
Sealed Air saw its share prices jump by 18.09 percent week-on-week as investor sentiment was fueled by reports that it is set to be acquired by investment firm Clayton, Dubilier...
Clearwater (CWAN) Jumps 19% as Firms Eye Takeover
We recently published 10 Market Movers That Made Millionaires in a Week. Clearwater Analytics Holdings Inc.
On Holding (ONON) Surges 21% on Earnings Blowout, Upbeat Outlook
On Holding grew its share prices by 21.14 percent week-on-week as investor sentiment was boosted by a stellar earnings performance that sparked a higher growth outlook for the...
Ondas Holdings (ONDS) Climbs 23% on Bullish Outlook, Q3 Blowout
Ondas Holdings soared by 23.58 percent week-on-week as investors took heart from an investment firm’s bullish outlook for the stock, while also cheering its stellar earnings...
Opendoor (OPEN) Soars 24% Ahead of Dividends
We recently published 10 Market Movers That Made Millionaires in a Week. Opendoor Technologies Inc.
Baytex (BTE) Climbs 25%, Extends 8-Day Run on Bullish Rating
Baytex Energy jumped by 25.4 percent week-on-week after an eight-day rally boosted by an investment firm’s bullish rating and news that it was officially exiting the US market...
Avadel (AVDL) Gets 26% Boost on Takeover Bid
We recently published 10 Market Movers That Made Millionaires in a Week.
Scholar Rock (SRRK) Soars 29% as Drug Candidate Progresses
We recently published 10 Market Movers That Made Millionaires in a Week. Scholar Rock Holding Corp.
Cidara (CDTX) Climbs 105% on $9.2-Billion Merger with Merck
Cidara Therapeutics soared by more than 100 percent week-on-week, as investors repositioned portfolios following news that it is set to be acquired by Merck Co.
Cogent Biosciences (COGT) Soars 126% on Stomach Cancer Treatment Progress
Cogent Biosciences skyrocketed by 126.3 percent week-on-week, as investor sentiment was boosted by the promising results of its last clinical trial that tested the efficacy of...
11 Overlooked Tech Stocks to Invest In
The past week, ending November 7, saw U.S. artificial intelligence-related stocks retreat amid mounting valuation concerns.
10 Market Movers That Made Millionaires in a Week
Ten companies skyrocketed last week, jumping by double and triple digits, as investor sentiment was fueled by a flurry of corporate developments, strong earnings performance, ...
Costco’s (COST) Been A Disappointment but I’d Never Sell It, Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down.
Lam Research’s (LRCX) Going to “Have Orders as Far as the Eye Can See,” Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down.
Poorly Run CarMax (KMX) “Misjudged” The Market, Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down. CarMax, Inc.
Intuit’s (INTU) Brand New Program Hasn’t Done Anything for the Stock, Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down. Intuit Inc.
Moving iMage Technologies, Inc. (AMEX:MITQ) Q1 2026 Earnings Call Transcript
Operator: Greetings. Welcome to Moving iMage Technologies, First Quarter 2026 Earnings Call. [Operator Instructions] Please note the conference is being recorded.
Koil Energy Solutions, Inc. (OTC:KLNG) Q3 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the Koil Energy Third Quarter 2025 Earnings Conference Call.
Nortech Systems Incorporated (NASDAQ:NSYS) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Nortex Systems Incorporated Third Quarter twenty twenty five Earnings Conference Call.
16 Latest Stocks on Jim Cramer’s Radar
In his latest appearance on CNBC's Squawk on the Street, Jim Cramer discussed trends in how wealthy Americans were spending their money and mentioned The Wall Street Journal's...
“FedEx (FDX) is the Economy,” Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down.
Everyone Should Watch Capital One (COF), Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down.
Block’s (XYZ) “Not That Great,” Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down. Block, Inc.
PayPal (PYPL) Having A Good CEO Hasn’t Meant Much, Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down. PayPal Holdings, Inc.
I’d Like to See Walmart (WMT) Go Higher, Says Jim Cramer
We recently published 9 Stocks Jim Cramer Talked About in a Show Where He Advised OpenAI to Slow Down. Walmart Inc.
10 Stocks Jim Cramer Talked About & Revealed Why He’s Critical Of OpenAI
In his latest appearance on CNBC's Squawk on the Street, Jim Cramer discussed General Atlantic's CEO Bill Ford's comments that we were not in an AI bubble and instead there appeared...
Jim Cramer Considers Lam Research a “Better Company” Than Applied Materials
Lam Research Corporation (NASDAQ:LRCX) is one of the stocks Jim Cramer discussed recently.
Jim Cramer Notes Conagra’s “Flat Revenues for Multiple Years”
Conagra Brands, Inc. (NYSE:CAG) is one of the stocks Jim Cramer discussed recently.
Jim Cramer on CarMax: “I Would Not Own That Stock”
“Okay, so look, I’ve gotta tell you, that was a very, very disrupting, a shocking departure by the CEO.
Jim Cramer on ServiceNow: “If You Invest for the Long Term, I Want You to Hold It”
“If you invest for the long term, I want you to hold it. And I think… it did in the Liberation era go down to $678. I don’t think that’s going to happen.
Jim Cramer on Coterra Energy: “This Stock’s Been Very Strong for the Past Couple Weeks”
Coterra Energy Inc. (NYSE:CTRA) is one of the stocks Jim Cramer discussed recently. Cramer highlighted that the Charitable Trust sold its Coterra stock in August.
Jim Cramer on Hertz: “It’s a Speculative Stock”
Hertz Global Holdings, Inc. (NASDAQ:HTZ) is one of the stocks Jim Cramer discussed recently.
Barclays (BCS) Upgraded to Buy as CFRA Highlights Strong Profitability and Earnings Resilience
Barclays PLC (NYSE:BCS) ranks among the best financial stocks to buy according to billionaire Ken Fisher.
Jim Cramer on American Express: “I Think That Company’s Great”
“Over the past few weeks, it looks like the experiential economy ain’t what it used to be… When you put it all together, it paints an increasingly negative picture of the...
S&P Raises Schwab (SCHW) Outlook After Strong Earnings and Better Interest-Rate Risk Controls
The Charles Schwab Corporation (NYSE:SCHW) ranks among the best financial stocks to buy according to billionaire Ken Fisher.
Bank of America (BAC) Gains Price Target Upgrade as Q3 Earnings Beat Analyst Expectations
Bank of America Corporation (NYSE:BAC) ranks among the best financial stocks to buy according to billionaire Ken Fisher.
Jim Cramer Says “Even Disney Seems to Anticipate a Near-Term Soft Spot”
The Walt Disney Company (NYSE:DIS) is one of the stocks Jim Cramer discussed recently.
Jim Cramer Highlights StubHub’s “Disappointing Result”
StubHub Holdings, Inc. (NYSE:STUB) is one of the stocks Jim Cramer discussed recently.
Visa (V) Beats Q4 Revenue Estimates as Strong U.S. Consumer Spending Drives Card Transactions
Visa Inc. (NYSE:V) ranks among the best financial stocks to buy according to billionaire Ken Fisher. On October 28, Visa Inc.
Hedge Fund Resource Center
